- Penn Medicine crisis center cuts psychiatric ED consults 80% in 6 months
- Maryland extends behavioral health provider enrollment halt
- TGH Behavioral Health launches partial hospitalization program
- NYU Langone, Mount Sinai patient records temporarily shielded from Justice Department
- UAMS to operate 53-bed Arkansas hospital, expanding clinical footprint
- New York system to close ASC, orthopedic group
- Preventing employee cynicism in a DSO
- Optum prepares to sell some New York specialties
- New York system to close orthopedic group, ASC
- CHS hospital CEO to retire after 50-year healthcare career
- Maintenance workers at 6 Prime hospitals in Illinois plan strike
- Walmart heiress’ nonprofit launches GME center to grow physician pipeline
- Optum prepares to sell some New York specialties
- Senate bill aims to expand rural surgery care
- Memorial Sloan Kettering breaks ground on $2.3B cancer center
- Ohio dentist to pay $500,000 to resolve False Claim Act allegations
- Lawmakers aim to fight ‘surgical deserts’ with new bill
- 9 schools training the next wave of ASC anesthesiologists
- 3 Washington dental offices pay $1M to settle Medicaid fraud allegations
- Why Ascension believes ASCs need a rebrand
- How long can health systems afford rising provider pay?
- Illinois behavioral health CEO charged in $75M Medicaid fraud case
- The anesthesia desert: 8 states, no residency programs, no pipeline
- The CRNA cost cliff
- Is private equity’s healthcare bubble about to burst?
- States ranked by anesthesiologists per capita
- ASCs’ lease liability
- Arizona behavioral health provider email breach affects 2,316
- Akron Children’s adds 24/7 text-based mental health support
- Kaiser Health Plan ordered to pay hospital $82M over insufficient reimbursement
- Dentistry’s highest-paid CEO
- US health spending set to reach $9T by 2034: CMS report
- What behavioral health leaders need to know about Medicaid work requirements
- Trial set for man accused of dental office shooting
- Utah halts new behavioral health Medicaid enrollments
- BCBS Michigan to supervised BH clinicians: Bill directly or face payment cuts
- Vitana Pediatric & Orthodontic Partners expands capital structure with new financing partner
- Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief
- Senators call for $50B rural health fund to better target small providers, relax spending restrictions
- Florida AG to probe CVS for anticompetitive pharmacy practices
- Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance
- UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates
- Even 5-Minute Movement Breaks Can Boost Your Mood And Fight Fatigue
- Lilly exec says MFN will affect company's obesity pill launch strategy in Europe: report
- Stada, under new CapVest ownership, picks up horde of European consumer brands
- Belly Laughs Spring From The Primitive Brain, Researchers Say
- Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
- Accelerated Aging May Explain Rising Cancer Risk In Young Adults
- Coval raises $28M series A to address AI voice agent reliability, compliance
- Amid safety concerns, ADC Therapeutics plots 17% staff cuts to push resources behind Zynlonta
- Racial Gaps Narrow For U.S. Cancer Deaths, Report Finds
- Medicare's AI Push Snarls Patients And Doctors In Errors And Delays
- Even in Blue States, Hospitals Have Continued To Drop Gender-Affirming Care for Youths
- Patients prefer healthcare providers' AI agents to public chatbots, with human oversight non‑negotiable, survey finds
- Revance taps dancer Julianne Hough to choreograph social media push for Botox rival
- Western University opens multidisciplinary dental clinic
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
- Oral Surgery Partners adds Pennsylvania practice
- Rock Dental Brands marks record growth during first half of 2026: 4 notes
- Connecticut woman accused of stealing $78K from dental office
- Some life insurers compete with health insurers on benefits. Here's why
- DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
- Psychologists sound alarm on patients using AI for mental health: 5 notes
- Locum tenens coverage becoming ‘more purposeful’ staffing strategy: Definitive Healthcare
- Testosterone Therapy Labels And Limits May Change Under FDA Proposal
- Unpacking CMS' decision to recalculate 2026 MA star ratings after Clover Health ruling
- Michigan hospitals denounce legislation to cap prices, limit mergers
- Incyte drops lawsuit as CMS relents on classification of Opzelura
- Medicare’s AI push snarls patients and doctors in errors and delays
- Midlife Strength Training Linked to Lower Diabetes Risk
- Badges, bots and blind spots
- Cadence secures $100M series C to advance AI-powered care for chronic disease
- Patient Portal Messages Double, Doctors Face Rising Workload
- Most Americans Unaware Of Link Between Alcohol And Cancer — And Aren't Interested In Spreading The Word, Either
- Sunscreen Misinformation Popular On TikTok, Study Finds
- Indiana Takes On Powerful Hospitals By Capping Prices They Charge Employers
- Kids’ Juice And Soda Intake Linked To Higher Blood Pressure Risk As Young Adults
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- Hallmark Health Care Solutions launches AI solution to tackle workforce ‘black box’
- AdvanCell locks in lease for US headquarters, radiopharmaceutical production near Boston
- Novartis’ ‘Relax Your Tight End’ prostate cancer campaign wins Cannes Lions Pharma Grand Prix
- These 'socially responsible' hospitals deliver on quality, value and equity
- A look at Elevance Health's push to streamline clinical reviews
- Whistleblower suit accuses Genentech, Novartis of running decades-long kickback scheme on allergy med Xolair
- Big obesity bets and China's rise fuel potential $2T in 2032 drug sales: Evaluate
- Patient portal messages doubled since 2020, study finds, underscoring challenges to physician workloads
- HCSC unveils Easify Edge plans as alternative employer option
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Half of U.S. adults can't afford healthcare, Gallup poll finds
- Ensemble Health Partners secures strategic growth investment from Thoreau
- Hospital margins inched higher in April, but still remain below 2025
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CARsgen makes history as China approves world's first CAR-T therapy for solid tumors
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- US to investigate Germany's proposed drug spending reforms
- Alnylam scolded over promotional activity after Pfizer complaint
- Real-world data powers next-gen biopharma
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- A 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Why a deviation investigation still takes two weeks in the age of AI
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Before you build or buy care navigation AI, answer this
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture
- Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund
- They’re Uninsured After Obamacare Became Too Costly. And They’re Far From Alone.
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
Michigan healthcare freedom community forum
Sharyl Attkisson recently highlighted a public health fact many of us have long suspected. Without ever precisely saying so, she nails it in "The Clot Factor," her November 27, 2023 episode of Full Measure.
Public health is not the front line of healthcare.
It is, in fact, a backwater.
And despite their expertise, their regulatory power, their overweening ambitions, and their state and federal capture of American research dollars and Americans' health data, public health officials never will be anything but the backwater of healthcare.
Why?
Because they have lost the art of observing and treating individual patients, as such. The public health focus is population care, and especially when it comes to new disease, their passion for mass treatment blinds them to essential details.
The episode takes less than 11 minutes to watch.
https://www.youtube.com/watch?v=rnpccYly_J8
The front line of healthcare resides where it always has: with the individual clinician dedicated to observantly, intelligently, and conscientiously caring for individual patients.
And as she documents, front-line clinicians, freed of bureaucratic restraints, are more powerful for individual care than ever before.
America is long overdue for our state and federal health policies and spending to reflect this reality.
Washington Post explores the CDC's recently predicted (though not to be released until April) downward revision of COVID guidelines.
Unsurprisingly given this winter's non-event for COVID, the recommendations match what many in the private sector said 2-3 years ago.
As stated in the original post, public health IS the backwater of modern medicine. The full article includes audio, video, and additional images that are omitted here due to length.
https://www.washingtonpost.com/health/2024/02/13/covid-isolation-guidelines-cdc-change/
Any guesses on how long this "new advice" will take to wind through MDHHS and down to county health department standard operating procedures?
CDC plans to drop five-day covid isolation guidelines
February 13, 2024 at 6:00 a.m. EST CDC officials acknowledged in internal discussions and in a briefing last week with state health officials how much the covid-19 landscape has changed since the virus emerged four years ago, killing nearly 1.2 million people in the United States and shuttering businesses and schools. The new reality — with most people having developed a level of immunity to the virus because of prior infection or vaccination — warrants a shift to a more practical approach, experts and health officials say.“Public health has to be realistic,” said Michael T. Osterholm, an infectious-disease expert at the University of Minnesota. “In making recommendations to the public today, we have to try to get the most out of what people are willing to do. … You can be absolutely right in the science and yet accomplish nothing because no one will listen to you.”
The CDC plans to recommend that people who test positive for the coronavirus use clinical symptoms to determine when to end isolation. Under the new approach, people would no longer need to stay home if they have been fever-free for at least 24 hours without the aid of medication and their symptoms are mild and improving, according to three agency officials who spoke on the condition of anonymity to share internal discussions.
The federal recommendations follow similar moves by Oregon and California. The White House has yet to sign off on the guidance that the agency is expected to release in April for public feedback, officials said. One agency official said the timing could “move around a bit” until the guidance is finalized.
Work on revising isolation guidance has been underway since last August but was paused in the fall as covid cases rose. CDC director Mandy Cohen sent staff a memo in January that listed “Pan-resp guidance-April” as a bullet point for the agency’s 2024 priorities.Officials said they recognized the need to give the public more practical guidelines for covid-19, acknowledging that few people are following isolation guidance that hasn’t been updated since December 2021. Back then, health officials cut the recommended isolation period for people with asymptomatic coronavirus from 10 days to five because they worried essential services would be hobbled as the highly transmissible omicron variant sent infections surging. The decision was hailed by business groups and slammed by some union leaders and health experts.
The plan to further loosen isolation guidance when the science around infectiousness has not changed is likely to prompt strong negative reaction from vulnerable groups, including people older than 65, those with weak immune systems and long-covid patients, CDC officials and experts said.
Doing so “sweeps this serious illness under the rug,” said Lara Jirmanus, a clinical instructor at Harvard Medical School and a member of the People’s CDC, a coalition of health-care workers, scientists and advocates focused on reducing the harmful effects of covid-19.Public health officials should treat covid differently from other respiratory viruses, she said, because it’s deadlier than the flu and increases the risk of developing long-term complications. As many as 7 percent of Americans report having suffered from a slew of lingering covid symptoms, including fatigue, difficulty breathing, brain fog, joint pain and ongoing loss of taste and smell, according to the CDC.
While the coronavirus continues to cause serious illness, especially among the most vulnerable people, vaccines and effective treatments such as Paxlovid are available. The latest versions of coronavirus vaccines were 54 percent effective at preventing symptomatic infection in adults, according to data released Feb. 1, the first U.S. study to assess how well the shots work against the most recent coronavirus variant. But CDC data shows only 22 percent of adults and 12 percent of children had received the updated vaccine as of Feb. 9, despite data showing the vaccines provide robust protection against serious illness.Coronavirus levels in wastewater indicate that symptomatic and asymptomatic infections remain high. About 20,000 people are still hospitalized — and about 2,300 are dying — every week, CDC data show. But the numbers are falling and are much lower than when deaths peaked in January 2021 when almost 26,000 people died of covid each week and about 115,000 were hospitalized.
The lower rates of hospitalizations were among the reasons California shortened its five-day isolation recommendation last month, urging people to stay home until they are fever-free for 24 hours and their symptoms are mild and improving. Oregon made a similar move last May.
California’s state epidemiologist Erica Pan said the societal disruptions that resulted from strict isolation guidelines also helped spur the change. Workers without sick leave and those who can’t work from home if they or their children test positive and are required to isolate bore a disproportionate burden. Strict isolation requirements can act as a disincentive to test when testing should be encouraged so people at risk for serious illness can get treatment, she said.
Giving people symptom-based guidance, similar to what is already recommended for flu, is a better way to prioritize those most at risk and balance the potential for disruptive impacts on schools and workplaces, Pan said. After Oregon made its change, the state has not experienced any disproportionate increases in community transmission or severity, according to data shared last month with the national association representing state health officials.
California still recommends people with covid wear masks indoors when they are around others for 10 days after testing positive — even if they have no symptoms — or becoming sick. “You may remove your mask sooner than 10 days if you have two sequential negative tests at least one day apart,” the California guidance states.It’s not clear whether the updated CDC guidance will continue to recommend masking for 10 days.
Health officials from other states told the CDC last week that they are already moving toward isolation guidelines that would treat the coronavirus the same as flu and RSV, with additional precautions for people at high risk, said Anne Zink, an emergency room physician and Alaska’s chief medical officer.
Many other countries, including the United Kingdom, Denmark, Finland, Norway and Australia, made changes to isolation recommendations in 2022. Of 16 countries whose policies California officials reviewed, only Germany and Ireland still recommend isolation for five days, according to a presentation the California public health department gave health officials from other states in January. The Singapore ministry of health, in updated guidance late last year, said residents could “return to normal activities” once coronavirus symptoms resolve.
Even before the Biden administration ended the public health emergency last May, much of the public had moved on from covid-19, with many people having long given up testing and masking, much less isolating when they come down with covid symptoms.Doctors say the best way for sick people to protect their communities is to mask or avoid unnecessary trips outside the home.
“You see a lot of people with symptoms — you don’t know if they have covid or influenza or RSV — but in all three of those cases, they probably shouldn’t be at Target, coughing, and looking sick,” said Eli Perencevich, an internal medicine professor at the University of Iowa.
Lena H. Sun
Washington, D.C.
National reporter focusing on health
Education: Cornell University, BS in communication; Columbia University, MA in journalism
Lena H. Sun is a national reporter for The Washington Post covering health, with a special focus on public health and infectious disease. A longtime reporter at The Post, she has covered a variety of beats, including the Metro transit system, immigration and education. She has also served as The Post's Beijing bureau chief.
Honors and Awards: Pulitzer Prize for National Reporting for coverage of the war on terrorism, part of national reporting team, 2002; Robert F. Kennedy journalism award, international print, 1994
Professional Affiliations: Association of Health Care Journalists
Languages spoken in addition to English: Mandarin, some French, some Spanish
And here's your answer:over three months later, reporting hospital admissions is over.
From my county's weekly newsletter, dated May 22, 2024.
COVID-19 Hospital Admissions
Effective May 1, 2024, hospitals are no longer required to report COVID-19 hospital admissions, hospital capacity, or hospital occupancy data to HHS through CDC’s National Healthcare Safety Network (NHSN). The data will be archived as of May 10, 2024, and available at United States COVID-19 Hospitalization Metrics by Jurisdiction, Timeseries.
And here's your answer:over three months later, reporting hospital admissions is over.
From my county's weekly newsletter, dated May 22, 2024.
COVID-19 Hospital Admissions
Effective May 1, 2024, hospitals are no longer required to report COVID-19 hospital admissions, hospital capacity, or hospital occupancy data to HHS through CDC’s National Healthcare Safety Network (NHSN). The data will be archived as of May 10, 2024, and available at United States COVID-19 Hospitalization Metrics by Jurisdiction, Timeseries.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















